2020 Future of Global Cancer Immunotherapy Market, Size, Share and Trend Analysis Report to 2026

1. 7/20/2020 Cancer Immunotherapy Market is estimated to grow at a significant CAGR of 13.24% between 2020 and 2026 (/) Cancer Immunotherapy Market is estimated to grow at a signi?cant CAGR of 13.24% between 2020 and 2026 NEWS PROVIDED BY OG Analysis (http://www.einpresswire.com/newsroom/oganalysis.com/) December 18, 2019, 07:15 GMT m/sharer.php?u=https%3A%2F%2Fwww.einpresswire.com%2Farticle%2F505160847%2Fcancer- stimated-to-grow-at-a-signi?cant-cagr-of-13-24-between-2020-and- apy+Market+is+estimated+to+grow+at+a+signi?cant+CAGR+of+13.24%25+between+2020+and+2026) nt/retweet?tweet_id=1207197604964118528) %2Fwww.einpresswire.com%2Farticle%2F505160847%2Fcancer-immunotherapy-market-is-estimated- -of-13-24-between-2020-and- herapy+Market+is+estimated+to+grow+at+a+signi?cant+CAGR+of+13.24%25+between+2020+and+2026) (http://www.linkedin.com/shareArticle? /cancer-immunotherapy-market-is-estimated-to-grow-at-a-signi?cant-cagr-of-13-24-between-2020- a550a8c4c8c4b93-fcd009c875a5577fd4fe2f5b7e3bf4eb.ssl.cf2.rackcdn.com/EINPresswire-505160847- ket-is-estimated-to-grow-at-a-signi?cant-cagr-of-13-24-between-2020-and-2026-2.pdf) https://www.einpresswire.com/article/505160847/cancer-immunotherapy-market-is-estimated-to-grow-at-a-significant-cagr-of-13-24-between-2020-and… 1/9

2. 7/20/2020 Cancer Immunotherapy Market is estimated to grow at a significant CAGR of 13.24% between 2020 and 2026 (/) (https://img.einpresswire.com/large/103285/cancer-immunotherapy-market- val.png#507x348) Cancer Immunotherapy Market Value and growth during 2020- 2026($ Billion) 2020 Future of Global Cancer Immunotherapy Market, Size, Share and Trend Analysis Report to 2026- Growth Opportunities, Competition, Forecasts, industry Outlook SOUTHLAKE, TX, UNITED STATES, December 18, 2019 /EINPresswire.com (http://www.einpresswire.com)/ -- Cancer Immunotherapy Market (https://www.oganalysis.com/industry-reports/217693/cancer-immunotherapy-market) size is aiming to reach new heights with a strong CAGR of 13.24% for the forecast period 2020-2026, notes OG Analysis. Based on the market drivers and trends, advancements in med-technology, prevalence of cancer and increasing cancer diagnosis rates triggers the market growth. Further, large volume of market players along with competitive growth of pharmaceutical companies the cancer immunotherapy market value is set to reach recordable growth. In addition, the idea of stimulating the immune system to attack tumor cells along with the shortcomings of the conventional cancer treatments positively impacts the cancer immunotherapy market growth through the forecast period. https://www.einpresswire.com/article/505160847/cancer-immunotherapy-market-is-estimated-to-grow-at-a-significant-cagr-of-13-24-between-2020-and… 2/9

3. 7/20/2020 Cancer Immunotherapy Market is estimated to grow at a significant CAGR of 13.24% between 2020 and 2026 Request Free Sample @ https://www.oganalysis.com/sample/217693 (/) (https://www.oganalysis.com/sample/217693) Supportive policy framework, growing cluster of Biopharma companies with focus on improving outcomes of cancer patients, R&D investments, and collaborative approach among key players showcase long term market growth opportunities for investors during the forecast period. Although there are many prospects in this market, clinical problems in terms of ef?cacy, patient-to-patient variability, and undesirable outcomes are factors negatively impacting the Cancer Immunotherapy market growth. In?ux of chronic diseases- Cancer drives the Cancer Immunotherapy market growth during the forecast According to the World Cancer Report, Cancer rates could increase by 50% to 15 million by 2020. This estimation of rising cases of cancer across nations predominantly drives the market participants to invest in R&D, innovative products and drives them to explore market growth opportunities. Browse Cancer Immunotherapy Market Research Report @ https://www.oganalysis.com/industry-reports/217693/cancer-immunotherapy-market (https://www.oganalysis.com/industry-reports/217693/cancer-immunotherapy-market) The ongoing register of cancer diseases of which approximately 85% of lung cancer cases are advised immunotherapy forces key OEMs to deliver niche drugs. Furthermore, the ongoing clinical trials for cancer therapeutic drugs in particular for non-small cell lung and biliary tract are observed across the market growth space. Non-pro?t organizations are observed to be increasingly entering cancer immunotherapy industry partnerships Academic and non-pro?t research institutes are observed to be concluding partnerships with industry players to provide innovative platforms that allow combination cancer https://www.einpresswire.com/article/505160847/cancer-immunotherapy-market-is-estimated-to-grow-at-a-significant-cagr-of-13-24-between-2020-and… 3/9

4. 7/20/2020 Cancer Immunotherapy Market is estimated to grow at a significant CAGR of 13.24% between 2020 and 2026 immunotherapies to be tested in clinical trials. Accordingly, the Foundation for the National Institutes of Health (FNIH) and the Cancer Research Institute (CRI) announced (/) CRI to be selected as source of landscape intelligence for cancer immunotherapy. Request for Special Discount on Cancer Immunotherapy Market report @ https://www.oganalysis.com/discount/217693 (https://www.oganalysis.com/discount/217693) Further, imCORE (immunotherapy Centers of Research Excellence) Network involves 26 leading cancer research institutions from 10 countries and key OEMs of cancer immunotherapy market such as Roche to develop new Cancer Immunotherapy treatment approaches. In addition, in 2019, the Society for Immunotherapy of Cancer (SITC) announced its inaugural Women in Cancer Immunotherapy Network (WIN) Leadership Institute to empower emerging female leaders and experts in cancer immunotherapy research from around the globe. Cancer Immunotherapy Market is set for rapid growth across health focus governing countries The cancer immunotherapy market size across Americas and EU is set to enter growth phase driven by active presence of cancer immunotherapy companies. According to a recent biomedical company statistics, 228 cancer immunotherapy vendors are present across United States followed by 123 companies across the EU. In addition, market growth is driven by strategic partnerships and product launches across key players of Europe. For instance, in 2019, Roche launched VENTANA PD-L1 Assay in European markets as companion diagnostic to identify triple-negative breast cancer patients. Key players in the EU are entering deals by investing huge sums, for instance, in 2019, GlaxoSmithKline teamed with Merck KGaA of Germany signed $4.2 billion deal to develop an experimental immunotherapy treatment for multiple dif?cult-to-treat cancers. https://www.einpresswire.com/article/505160847/cancer-immunotherapy-market-is-estimated-to-grow-at-a-significant-cagr-of-13-24-between-2020-and… 4/9

5. 7/20/2020 Cancer Immunotherapy Market is estimated to grow at a significant CAGR of 13.24% between 2020 and 2026 Further, in 2019, Genomics England (GeL) and Cambridge Cancer Genomics (AI-focused (/) Company) entered into a joint agreement to improve access to immunotherapy for cancer patients in the U.K. Further, the high prevalence of cancer with approximately 70% of deaths from cancer occur in low- and middle-income countries along with unmet needs of immuno- oncology treatments across Asia Paci?c that drives cancer immunotherapy market growth. Mergers and Acquisitions, huge R&D investments remain key growth strategies of leading immunotherapy market companies Key companies of cancer immunotherapy market are acquiring small and medium scale companies and entering into partnerships to develop new types of drugs that stimulate the immune system to ?ght cancer. This approach of M&A activities across the industry drives the market growth during the ?scal term. For instance, recently, Eli Lilly acquired small biotech for $1.6 billion to strengthen cancer immunotherapy pipeline. On similar lines, I-Mab and TRACON Pharmaceuticals announced strategic partnerships for multiple immuno-oncology programs. Further, key players are focusing on intense investments to acquire biotech companies and deliver immuno based cancer therapeutics. In 2018, Roche acquired UK Cancer Immunotherapy Biotech by investing €655M to develop one of its lead immunological cancer treatments. Prominent key players contributing major share include F. Hoffmann-La Roche AG, Merck & Co., Novartis International AG, GlaxoSmithKline Plc., Amgen Inc., Bristol-Myers Squibb, ELI Lilly and Company, Celgene Corporation, Seattle Genetics Inc., and Spectrum Pharmaceuticals Inc. Related Reports 1. Cancer Diagnostics Market (https://www.oganalysis.com/industry- reports/216142/cancer-diagnostics-market) 2. Lung Cancer Diagnostics Market (https://www.oganalysis.com/industry- https://www.einpresswire.com/article/505160847/cancer-immunotherapy-market-is-estimated-to-grow-at-a-significant-cagr-of-13-24-between-2020-and… 5/9

6. 7/20/2020 Cancer Immunotherapy Market is estimated to grow at a significant CAGR of 13.24% between 2020 and 2026 reports/216328/lung-cancer-diagnostics-market (https://www.oganalysis.com/industry- reports/216328/lung-cancer-diagnostics-market)) (/) OGAnalysis-Market Intelligence Platform (https://www.oganalysis.com/industry- reports/216535/global-oil-and-gas-database-subscription-services) Global Oil and gas industry annual subscription from OG ANALYSIS provides access to 11 databases including Exploration, Production, Re?nery, LNG, Oil and Chemicals Storage, Pipelines, Market Intelligence, CAPEX, Tankers, small LNG and Trade. About OG Analysis: OG Analysis has been a trusted research partner for 10+ years delivering most reliable analysis, information and innovative solutions. OG Analysis is one of the leading players in market research industry serving 980+ companies across multiple industry verticals. Our core client centric approach comprehends client requirements and provides actionable insights that enable users to take informed decisions. Contact Us: Anil Kumar Phone: +91-7337 01 3757 Email: sales@oganalysis.com Website: https://www.oganalysis.com (https://www.oganalysis.com) Follow Us on LinkedIn: https://www.linkedin.com/company/og-analysis/ (https://www.linkedin.com/company/og-analysis/) Anil Kumar OG Analysis +91 73370 13757 email us here (http://www.einpresswire.com/contact_author/505160847) You just read: https://www.einpresswire.com/article/505160847/cancer-immunotherapy-market-is-estimated-to-grow-at-a-significant-cagr-of-13-24-between-2020-and… 6/9

7. 7/20/2020 Cancer Immunotherapy Market is estimated to grow at a significant CAGR of 13.24% between 2020 and 2026 Cancer Immunotherapy Market is estimated to grow at a signi?cant CAGR of 13.24% between 2020 and 2026 (/) NEWS PROVIDED BY OG Analysis (http://www.einpresswire.com/newsroom/oganalysis.com/) December 18, 2019, 07:15 GMT /sharer.php?u=https%3A%2F%2Fwww.einpresswire.com%2Farticle%2F505160847%2Fcancer- mated-to-grow-at-a-signi?cant-cagr-of-13-24-between-2020-and- y+Market+is+estimated+to+grow+at+a+signi?cant+CAGR+of+13.24%25+between+2020+and+2026) retweet?tweet_id=1207197604964118528) Fwww.einpresswire.com%2Farticle%2F505160847%2Fcancer-immunotherapy-market-is-estimated- -13-24-between-2020-and- rapy+Market+is+estimated+to+grow+at+a+signi?cant+CAGR+of+13.24%25+between+2020+and+2026) (http://www.linkedin.com/shareArticle? ncer-immunotherapy-market-is-estimated-to-grow-at-a-signi?cant-cagr-of-13-24-between-2020- 50a8c4c8c4b93-fcd009c875a5577fd4fe2f5b7e3bf4eb.ssl.cf2.rackcdn.com/EINPresswire-505160847- -is-estimated-to-grow-at-a-signi?cant-cagr-of-13-24-between-2020-and-2026-2.pdf) https://www.einpresswire.com/article/505160847/cancer-immunotherapy-market-is-estimated- Distribution channels: Banking, Finance & Investment Industry (/channel/banking-?nance- investment), Business & Economy (/channel/business-economy), Healthcare & Pharmaceuticals Industry (/channel/healthcare-pharmaceuticals), Technology (/channel/technology), World & Regional (/channel/world-regional) EIN Presswire's priority is source transparency. We do not allow opaque clients, and our editors try to be careful about weeding out false and misleading content. As a user, if you see something we have missed, please do bring it to our attention. Your help is welcome. EIN Presswire, Everyone's Internet News Presswire™, tries to de?ne some of the boundaries that are reasonable in today's world. Please see our Editorial Guidelines (/editorial-guidelines) for more information. Contact Company/Organization https://www.einpresswire.com/article/505160847/cancer-immunotherapy-market-is-estimated-to-grow-at-a-significant-cagr-of-13-24-between-2020-and… 7/9

8. 7/20/2020 Cancer Immunotherapy Market is estimated to grow at a significant CAGR of 13.24% between 2020 and 2026 Anil Kumar OG Analysis +91 73370 13757 email us here (/contact-author/505160847) OG Analysis Lakshmi Sai Damam, Hi-Tech City Hyderabad, 500081 India +91 73370 13757 Visit Website (https://www.oganalysis.com) Visit Newsroom (http://www.einpresswire.com/newsroom/oganalysis.com (/) About OG Analysis has been a trusted research partner for 10+ years delivering most reliable analysis, information and innovative solutions. OG Analysis is one of the leading players in market research industry serving 980+ companies across multiple industry verticals. Our core client centric approach comprehends client requirements and provides actionable insights that enable users to take informed decisions. Contact Us: Anil Kumar Phone: +91-7337 01 3757 Email: sales@oganalysis.com () More From This Author Intravenous Immunoglobulin (IVIG) Market to grow with a CAGR of 7.2% over the forecast period 2020-2026 (/article/515187388/intravenous-immunoglobulin-ivig-market-to-grow-with-a-cagr-of- 7-2-over-the-forecast-period-2020-2026) Biologics Market to emerge with a robust growth of 10.4% CAGR over 2020-2026 (/article/515097733/biologics-market-to-emerge-with-a-robust-growth-of-10-4-cagr-over-2020- 2026) Animal Health Market to grow with a CAGR of 5.87% during the estimated time period 2020-2026 (/article/515097233/animal-health-market-to-grow-with-a-cagr-of-5-87-during-the-estimated- time-period-2020-2026) View All Stories From This Author (http://www.einpresswire.com/newsroom/oganalysis.com/) https://www.einpresswire.com/article/505160847/cancer-immunotherapy-market-is-estimated-to-grow-at-a-significant-cagr-of-13-24-between-2020-and… 8/9

9. 7/20/2020 Cancer Immunotherapy Market is estimated to grow at a significant CAGR of 13.24% between 2020 and 2026 (/) PR Distribution Newswires Press Releases Resources Help/Support Contact User Agreement (/user-agreement) Privacy Policy (/privacy-policy) Copyright Policy (/copyright) © 1995-2020 IPD Group, Inc. dba EIN Presswire All Right Reserved. https://www.einpresswire.com/article/505160847/cancer-immunotherapy-market-is-estimated-to-grow-at-a-significant-cagr-of-13-24-between-2020-and… 9/9